Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Immunity, Humoral"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 1872
Tytuł:
A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity.
Autorzy:
Stern D; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany. .
Meyer TC; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Treindl F; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Mages HW; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Krüger M; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Skiba M; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Krüger JP; Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Berlin, Berlin, Germany.
Zobel CM; Department of Internal Medicine, Bundeswehr Hospital Berlin, Berlin, Germany.
Schreiner M; Department of Internal Medicine, Bundeswehr Hospital Berlin, Berlin, Germany.
Grossegesse M; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Rinner T; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Peine C; Immunization Unit (FG 33), Department for Infectious Disease Epidemiology, Robert Koch Institute, 13353, Berlin, Germany.
Stoliaroff-Pépin A; Immunization Unit (FG 33), Department for Infectious Disease Epidemiology, Robert Koch Institute, 13353, Berlin, Germany.
Harder T; Immunization Unit (FG 33), Department for Infectious Disease Epidemiology, Robert Koch Institute, 13353, Berlin, Germany.
Hofmann N; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Michel J; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Nitsche A; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Stahlberg S; Central Epidemiological Laboratory (FG 22), Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101, Berlin, Germany.
Kneuer A; Central Epidemiological Laboratory (FG 22), Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101, Berlin, Germany.
Sandoni A; Central Epidemiological Laboratory (FG 22), Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101, Berlin, Germany.
Kubisch U; Central Epidemiological Laboratory (FG 22), Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101, Berlin, Germany.
Schlaud M; Central Epidemiological Laboratory (FG 22), Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101, Berlin, Germany.
Mankertz A; Measles, Mumps, Rubella, and Viruses Affecting Immunocompromised Patients (FG 12), Robert Koch Institute, 13353, Berlin, Germany.
Schwarz T; Institute of Virology, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.
Corman VM; Institute of Virology, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.; Corporate Member, Freie Universität Berlin, 10117, Berlin, Germany.; Corporate Member, Humboldt-Universität zu Berlin, 14195, Berlin, Germany.
Müller MA; Institute of Virology, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.
Drosten C; Institute of Virology, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.
de la Rosa K; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.; Berlin Institute of Health (BIH), Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.
Schaade L; Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Dorner MB; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany.
Dorner BG; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, 13353, Berlin, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 09; Vol. 13 (1), pp. 21846. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
Middle East Respiratory Syndrome Coronavirus*
Coronavirus OC43, Human*
Child ; Humans ; SARS-CoV-2 ; Immunity, Humoral ; Immunoglobulin G ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Host immune responses against African swine fever virus: Insights and challenges for vaccine development.
Autorzy:
Orosco FL; Virology and Vaccine Institute of the Philippines Program, Department of Science and Technology, Industrial Technology Development Institute, Taguig, Philippines.; S&T Fellows Program, Department of Science and Technology, Taguig, Philippines.; Department of Biology, College of Arts and Sciences, University of the Philippines Manila, Manila, Philippines.
Pokaż więcej
Źródło:
Open veterinary journal [Open Vet J] 2023 Dec; Vol. 13 (12), pp. 1517-1535. Date of Electronic Publication: 2023 Dec 31.
Typ publikacji:
Journal Article; Review
MeSH Terms:
African Swine Fever Virus*
African Swine Fever*/prevention & control
Swine Diseases*
Swine ; Animals ; Viral Proteins ; Immunity, Humoral ; Vaccine Development
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan.
Autorzy:
Masood KI; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Qaiser S; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Abidi SH; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
Khan E; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Mahmood SF; Department of Medicine, Aga Khan University, Karachi, Pakistan.
Hussain A; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Ghous Z; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Imtiaz K; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Ali N; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Hasan M; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Memon HA; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Yameen M; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Ali S; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Baloch S; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Lakhani G; Department of Medicine, Aga Khan University, Karachi, Pakistan.
Alves PM; iBET - Instituto de Biologia Experimental E Tecnológica, Oeiras, Portugal.
Iqbal NT; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.; Department of Pediatrics, Aga Khan University, Karachi, Pakistan.
Ahmed K; Department of Pediatrics, Aga Khan University, Karachi, Pakistan.
Iqbal J; Department of Pediatrics, Aga Khan University, Karachi, Pakistan.
Bhutta ZA; Center of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan.; Centre for Global Child Health, Hospital for Sick Children, Toronto, Canada.
Hussain R; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan.
Rottenberg M; Department of Microbiology and Tumor Cell Biology, Karolinska Institute, Stockholm, Sweden.
Simas JP; Católica Biomedical Research, Católica Medical School, Universidade Católica Portuguesa, Palma de Cima, 1649-023, Lisboa, Portugal.
Veldhoen M; Instituto de Medicina Molecular | João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Ghias K; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
Hasan Z; Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium Road, P.O.Box 3500, Karachi, 74800, Pakistan. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Dec 01; Vol. 23 (1), pp. 846. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*/epidemiology
Humans ; Pakistan/epidemiology ; Pandemics ; Seroepidemiologic Studies ; Spike Glycoprotein, Coronavirus ; T-Lymphocytes ; Immunoglobulin G ; Enzyme-Linked Immunospot Assay ; Antibodies, Viral ; Antibodies, Neutralizing ; Immunity, Humoral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents.
Autorzy:
Paniskaki K; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany. .; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany. .
Goretzki S; Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Anft M; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
Konik MJ; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Lechtenberg K; Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Vogl M; Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Meister TL; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Pfaender S; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Zettler M; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Jäger J; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
Dolff S; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Westhoff TH; Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
Rohn H; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Felderhoff-Mueser U; Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Stervbo U; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
Witzke O; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Dohna-Schwake C; Department of Pediatrics I, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Babel N; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.; Berlin Institute of Health at Charité - University Clinic Berlin, BIH Center for Regenerative Therapies (BCRT) Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Nov 22; Vol. 23 (1), pp. 818. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*
Adult ; Child ; Adolescent ; Humans ; Immunity, Cellular ; CD8-Positive T-Lymphocytes ; Immunity, Humoral ; Antibodies, Viral ; Antibodies, Neutralizing
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine.
Autorzy:
Liu X; Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University, No. 1098 Xueyuan Avenue, Shenzhen, 518000, Guangdong, China.
Min Q; Department of Pharmacy, First People's Hospital of Yunnan Province, Kunming University of Science and Technology, No. 157 Jinbi Road, Kunming, 650034, Yunnan, China.
Song H; Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University, No. 1098 Xueyuan Avenue, Shenzhen, 518000, Guangdong, China.; First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Yue A; Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University, No. 1098 Xueyuan Avenue, Shenzhen, 518000, Guangdong, China.; Centre of Integrated Chinese and Western Medicine, School of Clinical Medicine, Qingdao University, Qingdao, China.
Li Q; Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University, No. 1098 Xueyuan Avenue, Shenzhen, 518000, Guangdong, China.
Zhou Q; The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .
Han W; Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University, No. 1098 Xueyuan Avenue, Shenzhen, 518000, Guangdong, China. sugh_.
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Nov 22; Vol. 21 (1), pp. 441. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*
Nanoparticles*
Mice ; Animals ; Polymers ; Aluminum ; Hepatitis B Vaccines/therapeutic use ; Adjuvants, Immunologic ; Immunity, Cellular ; Immunity, Humoral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study.
Autorzy:
Hvidt AK; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Guo H; CellCarta, Montreal, QC, Canada.
Andersen R; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Lende SSF; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Vibholm LK; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Søgaard OS; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Schleimann MH; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Russell V; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Cheung AM; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.; Department of Medicine, University Health Network, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Paramithiotis E; CellCarta, Montreal, QC, Canada.
Olesen R; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark. .; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. .
Tolstrup M; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2023 Nov 16; Vol. 24 (1), pp. 45. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Humans ; Longitudinal Studies ; SARS-CoV-2 ; Immunity, Cellular ; Immunoglobulin G ; Antibodies, Viral ; Immunity, Humoral ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease.
Autorzy:
Yap DY; Division of Nephrology, Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Fong CH; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Shatin, Hong Kong Special Administrative Region, People's Republic of China.
Zhang X; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Ip JD; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Chan WM; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Chu AW; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Shatin, Hong Kong Special Administrative Region, People's Republic of China.
Chen LL; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Zhao Y; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Chan BP; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Luk KS; Department of Pathology, Princess Margaret Hospital, Kwai Chung, Hong Kong Special Administrative Region, People's Republic of China.
Cheng VC; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
Chan TM; Division of Nephrology, Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
To KK; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China. .; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Shatin, Hong Kong Special Administrative Region, People's Republic of China. .; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China. .; Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 15; Vol. 13 (1), pp. 19932. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Renal Insufficiency, Chronic*
Vaccines*
Adult ; Humans ; SARS-CoV-2 ; Immunity, Cellular ; Antibodies, Neutralizing ; Vaccination ; Antibodies, Viral ; Immunity, Humoral
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
Autorzy:
Moyo-Gwete T; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Richardson SI; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Keeton R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.
Hermanus T; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Spencer H; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Manamela NP; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Ayres F; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Makhado Z; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Motlou T; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
Tincho MB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.
Benede N; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.
Ngomti A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.
Baguma R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.
Chauke MV; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.
Mennen M; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa.; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town; Observatory, South Africa.; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Adriaanse M; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa.; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town; Observatory, South Africa.; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Skelem S; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa.; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town; Observatory, South Africa.; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.
Goga A; South African Medical Research Council, Cape Town, South Africa.
Garrett N; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.
Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Desmond Tutu HIV Centre, Cape Town, South Africa.
Gray G; South African Medical Research Council, Cape Town, South Africa.
Ntusi NAB; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, South Africa.; Cape Heart Institute, Faculty of Health Sciences, University of Cape Town; Observatory, South Africa.; South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, South Africa.
Riou C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, South Africa.
Burgers WA; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, South Africa.
Moore PL; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Nov 09; Vol. 19 (11), pp. e1011772. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Ad26COVS1*
COVID-19*/prevention & control
Humans ; SARS-CoV-2 ; Antibodies ; Vaccination ; Adaptive Immunity ; Antibodies, Viral ; Antibodies, Neutralizing ; Immunity, Humoral
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Mouse Sertoli Cells Inhibit Humoral-Based Immunity.
Autorzy:
Washburn RL; Immunology and Infectious Disease Concentration, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.; Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.
Kaur G; Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.; Department of Medical Education, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.
Dufour JM; Immunology and Infectious Disease Concentration, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.; Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.; Department of Medical Education, Texas Tech University Health Sciences Center, Lubbock, TX 79424, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 23; Vol. 23 (21). Date of Electronic Publication: 2022 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Immunity, Humoral*
Sertoli Cells*/metabolism
Male ; Humans ; Animals ; Mice ; Graft Survival ; Complement System Proteins/metabolism ; Immune Tolerance ; Graft Rejection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.
Autorzy:
Howells L; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Chan WY; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Sanchez E; Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, UK.
Horder J; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Newrick F; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Marfil J; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
McMillan A; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Wisniowski B; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Mahmood S; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Papanikolaou X; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Lee L; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.; Research Department of Haematology, UCL Cancer Institute, London, UK.
Wechalekar A; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Popat R; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Sive J; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Kyriakou C; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Xu K; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Nastouli E; Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, London, UK.
Yong KL; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.; Research Department of Haematology, UCL Cancer Institute, London, UK.
Rabin N; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2489-2493. Date of Electronic Publication: 2022 May 14.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Immunity, Humoral*
Antibodies, Viral ; COVID-19 Vaccines ; Humans ; Plasma Cells ; Vaccination
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects.
Autorzy:
de Boer J; Department of Public Health and Primary Care, KU Leuven Campus Kulak, Kortrijk, Belgium.
Saade U; R&D Department, InfYnity Biomarkers, Lyon, France.
Granjon E; R&D Department, InfYnity Biomarkers, Lyon, France.
Trouillet-Assant S; Virology Laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Civils Hospices of Lyon, Lyon, France.; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, Ecole Normale Supérieure de Lyon, Claude Bernard Lyon 1 University, Lyon, France.
Saade C; Virology Laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Civils Hospices of Lyon, Lyon, France.
Pottel H; Department of Public Health and Primary Care, KU Leuven Campus Kulak, Kortrijk, Belgium.
Zrein M; R&D Department, InfYnity Biomarkers, Lyon, France.
Pokaż więcej
Corporate Authors:
Covid ser study group
Źródło:
PloS one [PLoS One] 2022 Sep 29; Vol. 17 (9), pp. e0274553. Date of Electronic Publication: 2022 Sep 29 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Immunity, Humoral*
Antibodies, Viral ; Antigens, Viral ; BNT162 Vaccine ; Humans ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Profiling of humoral immune responses to norovirus in children across Europe.
Autorzy:
Villabruna N; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Izquierdo-Lara RW; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Schapendonk CME; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
de Bruin E; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Chandler F; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Thao TTN; Institute of Virology and Immunology (IVI), Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Westerhuis BM; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
van Beek J; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Sigfrid L; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Giaquinto C; Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University Hospital of Padua, Padua, Italy.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Bielicki JA; Paediatric Infectious Disease Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.; Department of Infectious Diseases and Vaccinology, University of Basel Children's Hospital (UKBB), Basel, Switzerland.
Kohns Vasconcelos M; Paediatric Infectious Disease Research Group, Institute for Infection and Immunity, St George's University of London, London, UK.; Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Fraaij PLA; Sophia Children's Hospital, Erasmus MC, Rotterdam, The Netherlands.
Koopmans MPG; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
de Graaf M; Department of Viroscience, Erasmus MC, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Aug 22; Vol. 12 (1), pp. 14275. Date of Electronic Publication: 2022 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Caliciviridae Infections*/immunology
Gastroenteritis*/immunology
Gastroenteritis*/virology
Immunity, Humoral*
Norovirus*/genetics
Capsid Proteins/genetics ; Child, Preschool ; Europe ; Genotype ; Humans ; Infant ; Phylogeny
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic Variation in the MBL2 Gene Is Associated with Chlamydia trachomatis Infection and Host Humoral Response to Chlamydia trachomatis Infection.
Autorzy:
Verweij SP; Department of Respiratory Medicine, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands.
Peters RPH; Research Unit, Foundation for Professional Development, East London 5200, South Africa.; Department of Medical Microbiology, University of Pretoria, Pretoria P.O. Box 14679, South Africa.
Catsburg A; MolGen B.V., 3905 NL Veenendaal, The Netherlands.
de Vries HJC; Cluster of Infectious Diseases, Public Health Service Amsterdam, 1018 WT Amsterdam, The Netherlands.; Center for Infection and Immunity Amsterdam (CINIMA), Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.; Department of Dermatology, Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.; Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM), 3720 BA Bilthoven, The Netherlands.
Ouburg S; Microbe & Lab B.V., 1105 AG Amsterdam, The Netherlands.
Morré SA; Department of Genetics and Cell Biology, Faculty of Health, Medicine & Life Sciences, Institute of Public Health Genomics, Research Institute GROW, University of Maastricht, 6216 LK Maastricht, The Netherlands.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Aug 18; Vol. 23 (16). Date of Electronic Publication: 2022 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Chlamydia Infections*/genetics
Chlamydia Infections*/immunology
Immunity, Humoral*
Mannose-Binding Lectin*/genetics
Antibodies, Bacterial ; Chlamydia trachomatis ; Female ; Haplotypes ; Humans ; Immunoglobulin G ; Netherlands ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
Autorzy:
Di Stefano A; Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, Respiratory Rehabilitation Unit of Veruno Institute, Via Per Revislate, 13, 28010, Veruno, NO, Italy. .
Dossena F; Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, Respiratory Rehabilitation Unit of Veruno Institute, Via Per Revislate, 13, 28010, Veruno, NO, Italy.
Gnemmi I; Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, Respiratory Rehabilitation Unit of Veruno Institute, Via Per Revislate, 13, 28010, Veruno, NO, Italy.
D'Anna SE; Divisione di Pneumologia, Istituti Clinici Scientifici Maugeri, SpA, Società Benefit, IRCCS, Telese, BN, Italy.
Brun P; Department of Molecular Medicine, Histology Unit, University of Padova, Padua, Italy.
Balbi B; Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, Respiratory Rehabilitation Unit of Veruno Institute, Via Per Revislate, 13, 28010, Veruno, NO, Italy.
Piraino A; Medical Affairs, Chiesi Italia SpA, Parma, Italy.
Spanevello A; Divisione di Pneumologia, Istituti Clinici Scientifici Maugeri, SpA, Società Benefit, IRCCS, Tradate, VA, Italy.
Nucera F; Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy.
Carriero V; Department of Clinical and Biological Sciences, Rare Lung Disease Unit and Severe Asthma Centre, San Luigi Gonzaga University Hospital, University of Turin, Orbassano, Turin, Italy.
Bertolini F; Department of Clinical and Biological Sciences, Rare Lung Disease Unit and Severe Asthma Centre, San Luigi Gonzaga University Hospital, University of Turin, Orbassano, Turin, Italy.
Maniscalco M; Divisione di Pneumologia, Istituti Clinici Scientifici Maugeri, SpA, Società Benefit, IRCCS, Telese, BN, Italy.
Adcock IM; National Heart and Lung Institute, Imperial College London, London, UK.
Caramori G; Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy.
Ricciardolo FLM; Department of Clinical and Biological Sciences, Rare Lung Disease Unit and Severe Asthma Centre, San Luigi Gonzaga University Hospital, University of Turin, Orbassano, Turin, Italy.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2022 Aug 03; Vol. 23 (1), pp. 200. Date of Electronic Publication: 2022 Aug 03.
Typ publikacji:
Journal Article
MeSH Terms:
Immunity, Humoral*
Pulmonary Disease, Chronic Obstructive*/metabolism
Biomarkers/metabolism ; Bronchi/metabolism ; Humans ; Hydrogen Peroxide/metabolism ; Immunoglobulin A, Secretory/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination.
Autorzy:
Oktelik FB; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Yilmaz V; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Gelmez MY; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Akdeniz N; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Pamukcu C; Department of Molecular Biology and Genetics, Bogazici University, Istanbul, Turkey.
Sutlu T; Department of Molecular Biology and Genetics, Bogazici University, Istanbul, Turkey.
Kose M; Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Tuzun E; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Deniz G; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Pokaż więcej
Źródło:
Canadian journal of microbiology [Can J Microbiol] 2022 Aug 01; Vol. 68 (8), pp. 543-550. Date of Electronic Publication: 2022 Jul 19.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/immunology
Immunity, Humoral*
Antibodies, Viral ; Humans ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin M ; Nucleocapsid Proteins ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Flt3 Signaling in B Lymphocyte Development and Humoral Immunity.
Autorzy:
Medina KL; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jun 30; Vol. 23 (13). Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunity, Humoral*
Lymphopoiesis*/physiology
Animals ; B-Lymphocytes ; Cell Differentiation ; Hematopoietic Stem Cells ; Ligands ; Mice ; fms-Like Tyrosine Kinase 3/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.
Autorzy:
Dasari V; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Beckett K; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Horsefield S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Ambalathingal G; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Khanna R; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Jun 23; Vol. 18 (6), pp. e1010403. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytomegalovirus Infections*
Immunity, Humoral*
Adjuvants, Immunologic ; Animals ; Antibodies, Viral ; CD8-Positive T-Lymphocytes ; Epitopes, T-Lymphocyte/metabolism ; Humans ; Immunity, Cellular ; Mice ; Oligodeoxyribonucleotides ; Toll-Like Receptor 9/metabolism ; Vaccines, Combined ; Vaccines, Subunit
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin.
Autorzy:
Mohammad L; Department of Transplant and Infection Immunology, Saarland University, 66421, Homburg, Germany.
Fousse M; Department of Neurology, Saarland University, Homburg, Germany.
Wenzel G; Department of Otorhinolaryngology, Saarland University, Homburg, Germany.
Flotats Bastardas M; Department of Pediatrics and Neonatology, Saarland University, Homburg, Germany.
Faßbender K; Department of Neurology, Saarland University, Homburg, Germany.
Dillmann U; Department of Neurology, Saarland University, Homburg, Germany.
Schick B; Department of Otorhinolaryngology, Saarland University, Homburg, Germany.
Zemlin M; Department of Pediatrics and Neonatology, Saarland University, Homburg, Germany.
Gärtner BC; Department of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Sester U; SHG Klinikum Völkingen, Völklingen, Germany.
Schub D; Department of Transplant and Infection Immunology, Saarland University, 66421, Homburg, Germany.
Schmidt T; Department of Transplant and Infection Immunology, Saarland University, 66421, Homburg, Germany.
Sester M; Department of Transplant and Infection Immunology, Saarland University, 66421, Homburg, Germany. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 Oct 25; Vol. 20 (1), pp. 246. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Facial Paralysis*
Herpes Zoster*
Humans ; CTLA-4 Antigen ; Immunity, Humoral ; Ki-67 Antigen ; Herpesvirus 3, Human ; Simplexvirus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Humoral immune response and changes in peritoneal cell populations in rats immunized against two Leptospira serovars; serovar patoc and serovar pyrogenes.
Autorzy:
Gangani D; Institute of Biochemistry Molecular Biology and Biotechnology, University of Colombo, Colombo 03, Colombo, Sri Lanka. .
Dissanayake W; Institute of Biochemistry Molecular Biology and Biotechnology, University of Colombo, Colombo 03, Colombo, Sri Lanka.
de Silva R; Department of Immunology, Medical Research Institute, Colombo 08, Colombo, Sri Lanka.
Anuradha K; Institute of Biochemistry Molecular Biology and Biotechnology, University of Colombo, Colombo 03, Colombo, Sri Lanka.
Karunanayake L; Department of Bacteriology, Medical Research Institute, Colombo 08, Colombo, Sri Lanka.
Fernando N; Institute of Biochemistry Molecular Biology and Biotechnology, University of Colombo, Colombo 03, Colombo, Sri Lanka.
Rajapakse S; Postgraduate Institute of Medicine, University of Colombo, Colombo 08, Colombo, Sri Lanka.
Premawansa S; Department of Zoology and Environment Sciences, Faculty of Science, University of Colombo, Colombo 03, Colombo, Sri Lanka.
Handunnetti S; Institute of Biochemistry Molecular Biology and Biotechnology, University of Colombo, Colombo 03, Colombo, Sri Lanka.
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2023 Oct 17; Vol. 24 (1), pp. 39. Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leptospira*
Leptospirosis*/diagnosis
Rats ; Animals ; Serogroup ; Immunity, Humoral ; Lipopolysaccharides ; Rats, Wistar ; Antigens, Bacterial ; Immunoglobulin G ; Immunoglobulin M
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sex-Specific Immune Responses to Seasonal Influenza Vaccination in Diabetic Individuals: Implications for Vaccine Efficacy.
Autorzy:
Sengupta A; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden.
Al-Otaibi N; King Abdulaziz City for Science and Technology (KACST), Riyad 11442, Saudi Arabia.
Hinkula J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58185, Sweden.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2023 Oct 17; Vol. 2023, pp. 3111351. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Diabetes Mellitus*
Male ; Female ; Humans ; Vaccine Efficacy ; Seasons ; Vaccination ; Immunity, Humoral ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 1872

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies